GQ262 Attenuates Pathological Cardiac Remodeling by Downregulating the Akt/mTOR Signaling Pathway
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms251910297 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Haoyue Ma und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Basic Medical Sciences, Peking University Health Science Center, 38 Xueyuan Road, Haidian District, Beijing 100…. Hauptthemen laut MEDLINE: Cardiomegaly, Myocytes, Cardiac, Proto-Oncogene Proteins c-akt, Signal Transduction. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Natural Science Foundation of China, The Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.
Abstract (Originalsprache)
Cardiac remodeling, a critical process that can lead to heart failure, is primarily characterized by cardiac hypertrophy. Studies have shown that transgenic mice with Gαq receptor blockade exhibit reduced hypertrophy under induced pressure overload. GQ262, a novel Gαq/11 inhibitor, has demonstrated good biocompatibility and specific inhibitory effects on Gαq/11 compared to other inhibitors. However, its role in cardiac remodeling remains unclear. This study aims to explore the anti-cardiac remodeling effects and mechanisms of GQ262 both in vitro and in vivo, providing data and theoretical support for its potential use in treating cardiac remodeling diseases. Cardiac hypertrophy was induced in mice via transverse aortic constriction (TAC) for 4 weeks and in H9C2 cells through phenylephrine (PE) induction, confirmed with WGA and H&E staining. We found that GQ262 improved cardiac function, inhibited the protein and mRNA expression of hypertrophy markers, and reduced the levels of apoptosis and fibrosis. Furthermore, GQ262 inhibited the Akt/mTOR signaling pathway activation induced by TAC or PE, with its therapeutic effects disappearing upon the addition of the Akt inhibitor ARQ092. These findings reveal that GQ262 inhibits cardiomyocyte hypertrophy and apoptosis through the Akt/mTOR signaling pathway, thereby reducing fibrosis levels and mitigating cardiac remodeling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, School of Basic Medical Sciences, Peking University Health Science Center, 38 Xueyuan Road, Haidian District, Beijing 100191, China.
- State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing 100191, China.
- NHC Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Peking University, Beijing 100191, China.
- Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, Peking University, Beijing 100191, China.
- State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China.
- State Key Laboratory of Anti-Infective Drug Discovery and Development, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
ORCID-Profile: Haoyue Ma, Xiaofeng Xiong, Rong Qi
Förderung
- The National Natural Science Foundation of China
- The Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- Beijing Natural Science Foundation
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Ma, H., Ge, Y., Di, C., Wang, X., Qin, B., Wang, A., Hu, W., Lai, Z., Xiong, X., & Qi, R. (2024). GQ262 Attenuates Pathological Cardiac Remodeling by Downregulating the Akt/mTOR Signaling Pathway. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251910297
Vancouver
Ma H, Ge Y, Di C, Wang X, Qin B, Wang A, et al. GQ262 Attenuates Pathological Cardiac Remodeling by Downregulating the Akt/mTOR Signaling Pathway. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251910297
BibTeX
@article{Ma2024,
author = {Ma, Haoyue and Ge, Yang and Di, Chang and Wang, Xin and Qin, Boyang and Wang, Anhui and Hu, Weipeng and Lai, Zirui and Xiong, Xiaofeng and Qi, Rong},
title = {GQ262 Attenuates Pathological Cardiac Remodeling by Downregulating the Akt/mTOR Signaling Pathway},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms251910297}
}
EUVIMED